Probiotic Supplementation and its Potential Benefits in Type 2 Diabetes: A Meta-analysis.

Colella M, Mandorino M, Garzone S, Maggiore ME, Capozzi L, Bilancia M.

DOI: 10.2174/0118715303425888251212053249
Published: 2026-01-01
Container: Endocr Metab Immune Disord Drug Targets
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.2174/0118715303425888251212053249,
  title = {Probiotic Supplementation and its Potential Benefits in Type 2 Diabetes: A Meta-analysis.},
  author = {Colella M and  Mandorino M and  Garzone S and  Maggiore ME and  Capozzi L and  Bilancia M.},
  year = {2026},
  journal = {Endocr Metab Immune Disord Drug Targets},
  doi = {10.2174/0118715303425888251212053249},
  url = {https://doi.org/10.2174/0118715303425888251212053249}
}

RIS

TY  - JOUR
TI  - Probiotic Supplementation and its Potential Benefits in Type 2 Diabetes: A Meta-analysis.
AU  - Colella M
AU  -  Mandorino M
AU  -  Garzone S
AU  -  Maggiore ME
AU  -  Capozzi L
AU  -  Bilancia M.
PY  - 2026
JO  - Endocr Metab Immune Disord Drug Targets
DO  - 10.2174/0118715303425888251212053249
UR  - https://doi.org/10.2174/0118715303425888251212053249
ER  -

APA

M, C., M, M., S, G., ME, M., L, C., & M., B. (2026). Probiotic Supplementation and its Potential Benefits in Type 2 Diabetes: A Meta-analysis.. Endocr Metab Immune Disord Drug Targets. https://doi.org/10.2174/0118715303425888251212053249

Source records

europe-pmc · retrieved 2026-09-27T07:36:45.850Z